Filed before 2025Filed 25 October 2021
Cedilla Therapeutics, Inc. has sold $82.6M so far
Cedilla Therapeutics, Inc., a biotech company based in Cambridge, MA, has sold $82.6M so far in its equity round, according to a filing dated 25 October 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 25 October 2021
- First filed
- 24 September 2020
- Round
- Equity round (amended filing)
- Amount sold
- $82.6M
- Offering size
- $82.6M
- Investors so far
- 24
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 88% of the 2,220 tracked raises with an amount filed in 2021, and than 79% of the 177 in biotech.
Cedilla Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 25 Oct 2021 | Amended filing | $82.6M | This raise |
| 9 Sep 2021 | Amended filing | $57.6M | This raise |
| 24 Sep 2020 | New filing | $30.4M | This raise |
More with Third Rock Ventures on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.